DexCom, Inc.

NasdaqGS:DXCM Lagerbericht

Marktkapitalisierung: US$27.1b

DexCom Management

Management Kriterienprüfungen 4/4

DexCom's CEO ist Kevin Sayer , ernannt in Jun 2011, hat eine Amtszeit von 16.58 Jahren. Die jährliche Gesamtvergütung beträgt $15.71M , bestehend aus 7% Gehalt und 93% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.044% der Aktien des Unternehmens, im Wert von $20.31M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.4 Jahre bzw. 8.4 Jahre.

Wichtige Informationen

Kevin Sayer

Geschäftsführender

US$15.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts7.0%
Amtszeit als Geschäftsführer13.3yrs
Eigentum des Geschäftsführers0.04%
Durchschnittliche Amtszeit des Managements2.7yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder8.7yrs

Jüngste Management Updates

Recent updates

DexCom: Investors Discounting Long CGM Growth Runway

Sep 19

We Like These Underlying Return On Capital Trends At DexCom (NASDAQ:DXCM)

Sep 16
We Like These Underlying Return On Capital Trends At DexCom (NASDAQ:DXCM)

DexCom Q2 Earnings: Traditional Market Overreaction

Aug 07

Is Now The Time To Look At Buying DexCom, Inc. (NASDAQ:DXCM)?

Jul 26
Is Now The Time To Look At Buying DexCom, Inc. (NASDAQ:DXCM)?

DexCom Q2: Surprising Earnings Miss With Hints Of Competitive Pressures

Jul 26

Why Investors Shouldn't Be Surprised By DexCom, Inc.'s (NASDAQ:DXCM) P/E

Jul 12
Why Investors Shouldn't Be Surprised By DexCom, Inc.'s (NASDAQ:DXCM) P/E

DexCom's ADA Conference Takeaways: Stelo, CGM Tailwinds Still Intact

Jul 03

DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly

Jun 28
DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly

Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Jun 03
Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Dexcom: Positive Catalysts Ahead To Support Growth

May 13

If EPS Growth Is Important To You, DexCom (NASDAQ:DXCM) Presents An Opportunity

May 07
If EPS Growth Is Important To You, DexCom (NASDAQ:DXCM) Presents An Opportunity

DexCom: Attractive Discount After Strong Earnings Results

May 06

Returns At DexCom (NASDAQ:DXCM) Are On The Way Up

Apr 25
Returns At DexCom (NASDAQ:DXCM) Are On The Way Up

Why We're Not Concerned About DexCom, Inc.'s (NASDAQ:DXCM) Share Price

Apr 12
Why We're Not Concerned About DexCom, Inc.'s (NASDAQ:DXCM) Share Price

DexCom Is Pricey For A Reason - Its Growth Story Reflects That

Apr 11

Is DexCom (NASDAQ:DXCM) Using Too Much Debt?

Mar 29
Is DexCom (NASDAQ:DXCM) Using Too Much Debt?

Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

Mar 04
Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

DexCom: A Wealth Compounder In Healthcare

Feb 14

DexCom: Stelo Stellar Outlook

Jan 17

DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital

Jan 15
DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital

DexCom, Inc. (NASDAQ:DXCM) Not Lagging Industry On Growth Or Pricing

Jan 01
DexCom, Inc. (NASDAQ:DXCM) Not Lagging Industry On Growth Or Pricing

DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly

Dec 18
DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly

A Look At The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Dec 05
A Look At The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

At US$109, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List?

Nov 21
At US$109, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List?

DexCom (NASDAQ:DXCM) Is Looking To Continue Growing Its Returns On Capital

Sep 28
DexCom (NASDAQ:DXCM) Is Looking To Continue Growing Its Returns On Capital

DexCom (NASDAQ:DXCM) Could Easily Take On More Debt

Sep 13
DexCom (NASDAQ:DXCM) Could Easily Take On More Debt

Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Aug 29
Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

Aug 14
Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet

Jun 05
DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet

There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital

May 16
There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital

Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention?

Mar 21
Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention?

These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely

Mar 03
These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely

DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price

Feb 13
DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price

DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly

Nov 25
DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Kevin Sayer im Vergleich zu den Einnahmen von DexCom verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

US$667m

Mar 31 2024n/an/a

US$639m

Dec 31 2023US$16mUS$1m

US$542m

Sep 30 2023n/an/a

US$377m

Jun 30 2023n/an/a

US$358m

Mar 31 2023n/an/a

US$293m

Dec 31 2022US$15mUS$953k

US$341m

Sep 30 2022n/an/a

US$244m

Jun 30 2022n/an/a

US$230m

Mar 31 2022n/an/a

US$258m

Dec 31 2021US$12mUS$900k

US$217m

Sep 30 2021n/an/a

US$577m

Jun 30 2021n/an/a

US$562m

Mar 31 2021n/an/a

US$530m

Dec 31 2020US$14mUS$800k

US$550m

Sep 30 2020n/an/a

US$231m

Jun 30 2020n/an/a

US$205m

Mar 31 2020n/an/a

US$148m

Dec 31 2019US$10mUS$691k

US$101m

Sep 30 2019n/an/a

-US$171m

Jun 30 2019n/an/a

-US$170m

Mar 31 2019n/an/a

-US$130m

Dec 31 2018US$10mUS$601k

-US$127m

Sep 30 2018n/an/a

US$43m

Jun 30 2018n/an/a

-US$5m

Mar 31 2018n/an/a

-US$33m

Dec 31 2017US$8mUS$546k

-US$50m

Vergütung im Vergleich zum Markt: KevinDie Gesamtvergütung ($USD15.71M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD13.53M).

Entschädigung vs. Einkommen: KevinDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Kevin Sayer (66 yo)

13.3yrs

Amtszeit

US$15,712,244

Vergütung

Mr. Kevin Ronald Sayer has been Executive Chairman of DexCom, Inc. since July 30, 2018. Mr. Sayer has been the Chief Executive Officer of DexCom, Inc. since January 5, 2015 and as its President since June...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Kevin Sayer
Executive Chairman13.3yrsUS$15.71m0.043%
$ 11.8m
Jereme Sylvain
Executive VP4.5yrsUS$4.25m0.0088%
$ 2.4m
Jacob Leach
Executive VP & COO2.1yrsUS$4.94m0.065%
$ 17.5m
Michael Brown
Executive VP & Chief Legal Officer2.7yrsUS$4.34m0.0013%
$ 359.9k
Teri Lawver
Executive VP & Chief Commercial Officer1.7yrsUS$6.53m0.0016%
$ 443.8k
Girish Naganathan
Executive VP & CTO1.9yrsUS$4.05m0.0013%
$ 362.6k
Stacey Stewart
Senior VP & Chief Information Officerless than a yearkeine Datenkeine Daten
Sean Christensen
Director of Corporate Affairs & Head of Investor Relationsno datakeine Datenkeine Daten
Matthew Dolan
Executive Vice President of Strategy3.5yrskeine Daten0%
$ 0
Leverne Marsh
Executive Vice President of Marketingless than a yearkeine Datenkeine Daten
Sadie Stern
Executive VP & Chief Human Resources Officer4yrskeine Daten0.0058%
$ 1.6m
Steven Pacelli
Executive VP & MD of Dexcom Ventures3.4yrsUS$3.02m0.021%
$ 5.8m

2.7yrs

Durchschnittliche Betriebszugehörigkeit

49yo

Durchschnittliches Alter

Erfahrenes Management: DXCMDas Führungsteam des Unternehmens gilt als erfahren (2.4 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Kevin Sayer
Executive Chairman16.8yrsUS$15.71m0.043%
$ 11.8m
Mark Foletta
Lead Independent Director9.8yrsUS$393.51k0.014%
$ 3.8m
Steven Altman
Independent Director10.8yrsUS$343.40k0.014%
$ 3.8m
Eric Topol
Independent Director15.2yrsUS$346.49k0.094%
$ 25.5m
Nicholas Augustinos
Independent Director14.8yrsUS$362.21k0.0092%
$ 2.5m
Bridgette Heller
Independent Director5yrsUS$346.49k0.0054%
$ 1.5m
Kyle Malady
Independent Director3.9yrsUS$343.40k0.0039%
$ 1.0m
Karen Dahut
Independent Director4.1yrsUS$345.90k0.0038%
$ 1.0m
Richard Collins
Independent Director7.5yrsUS$345.90k0.0098%
$ 2.7m
Rimma Driscoll
Independent Director1.1yrsUS$404.72k0%
$ 0

8.7yrs

Durchschnittliche Betriebszugehörigkeit

63yo

Durchschnittliches Alter

Erfahrener Vorstand: DXCMDie Vorstandsmitglieder gelten als erfahren (8.4 Jahre durchschnittliche Amtszeit).